Related Experiment Video
Updated: Jan 15, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Tumor microenvironment and macroenvironment: A new perspective on holistic oncology
Qun Chen1, Kuirong Jiang2, Michael S Bronze1
1Department of Medicine, The University of Oklahoma Health Campus, Oklahoma City, OK, 73104, USA.
The tumor microenvironment (TME) and tumor macroenvironment (TMaE) interact to influence cancer progression and treatment outcomes. Understanding this local-systemic crosstalk is crucial for developing advanced cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The tumor microenvironment (TME) and tumor macroenvironment (TMaE) are critical determinants of cancer initiation, progression, and therapeutic resistance.
- The TME encompasses local cellular niches, while the TMaE integrates systemic signals like metabolism, immunity, and inflammation.
- Current models inadequately represent the complex interplay between local and systemic factors in cancer.
Purpose of the Study:
- To review the distinct and overlapping roles of the TME and TMaE in shaping cancer biology.
- To highlight the mechanisms through which systemic factors influence local tumor ecosystems.
- To emphasize the need for integrated models to understand local-systemic crosstalk in cancer.
Main Methods:
- Literature review of recent advances in cancer biology, focusing on TME and TMaE interactions.
- Analysis of how systemic physiological factors impact tumor progression and treatment response.
- Discussion of current limitations in conceptualizing and modeling TME-TMaE crosstalk.
Main Results:
- Both TME and TMaE are integral to tumor initiation, progression, dormancy, and metastasis.
- Systemic factors (aging, metabolic imbalance, inflammation, stress) significantly remodel the TME and influence cancer outcomes.
- The interaction between local tumor niches and systemic physiology is complex and bidirectional.
Conclusions:
- A comprehensive understanding of TME-TMaE interactions is essential for refining precision oncology and preventive strategies.
- Future research should integrate multi-omics, advanced imaging, and humanized models to elucidate local-systemic crosstalk.
- Targeting both local and systemic cancer ecosystems offers a promising avenue for combinatorial therapies.
Related Concept Videos
The Tumor Microenvironment
Dimensions of Health and Illness
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

